[1] Retatrutide: What the Evidence Actually Shows Retatrutides pivotal obesity dataset is a Phase 2, double-blind, randomised, placebo-controlled trial in adults with obesity (or overweight plus a weight-related condition), testing once-weekly doses up to 12 mg over 48 weeks
Impairment of auditory brainstem response wave I in tinnitus patients: Evidence and confounds
A 2025 pilot study infused up to 20 mg of BPC157 intravenously in 2 healthy adults and reported no adverse effects and no abnormal changes in heart, liver, kidney, thyroid, or bloodglucose markers
These antioxidant-infused injections are renowned for their skin rejuvenating properties, and they are considered safer when compared to using Glutathione alone
This leads many people to look toward supplementation